|
CME Disclosure METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND OTHER RESISTANT INFECTIONS: AN EXPERT DEBATE Release date: January 2008 Method of Participation There are no fees for participating and receiving CME credit for this activity. During the period January 1, 2008 through December 31, 2008, participants must:
This online CME activity should take approximately 1.5 hours to complete. This activity consists of 4 slide presentations. To complete this activity the participant should, in order, read the CME information, view each slide presentation in its entirety, go to the link provided at the end of the activity to take the posttest, complete the registration and evaluation, and print the CME certificate. The evaluation form provides each participant with the opportunity to comment on the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his or her views on future educational needs. To receive credit for this activity, follow the instructions provided on the posttest. If you have questions, you can contact the Dannemiller Foundation at editor@dannemiller.com. The activity expires on December 31, 2008 and no credit will be awarded after this date. Faculty John G. Bartlett, MD – Chairman Louis B. Rice, MD Dennis L. Stevens, MD, PhD Gregory J. Moran, MD, FACEP Robert C. Moellering, Jr., MD, MACP Table of Contents:
Target Audience This activity is designed for infectious disease specialists, microbiologists, and other health care personnel who participate in the selection of antibiotics for treatment of patients with infections caused by resistant bacterial strains, including MRSA. Needs Assessment and Program Description This online presentation of an interactive live symposium that was a satellite to the ASM 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, in Chicago, September 19, 2007 will highlight Methicillin-resistant Staphylococcus aureus (MRSA) and other resistant cSSSi and HAP/VAP infections, and will compare and contrast conventional and emrging antimicrobial therapies. Infectious disease physicians have come to realize that serious, life-threatening infections, such as cSSSis and HAP/VAP, particularly with highly resistant bacterial strains, continue to result in unacceptably high levels of morbidity and mortality. To help stem the high morbidity and mortality rates associated with MRSA and other resistant bacterial infections, infectious disease specialists require education on the types of infections, potential pathogens involved, current treatment guidelines and the role of newer antimicrobial agents in the management of MRSA and other resistant bacterial infections. Lastly, "pathogen-focused therapy" is a new concept which uses culture data and clinical findings to define and adjust a patient's antibiotic therapy. Symposium faculty have been asked to include the shifting epidemiology of MRSA and other resistant bacterial infections, guidelines for the evaluation and treatment of cSSSi and HAP/VAP infections, and the use of newer antimicrobial therapies in the prevention and treatment of these serious, life-threatening infections. Learning Objectives Upon completion of this CME activity, participants should be better able to:
Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Dannemiller Memorial Educational Foundation and Exemplar CE. The Dannemiller Memorial Educational Foundation is accredited by the ACCME to provide continuing medical education for physicians. Designation Statement The Dannemiller Memorial Educational Foundation designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. To Claim CME Credits The viewer must click on the link at the end of the webcast to complete the post-test and evaluation form. Faculty Disclosures In accordance with the Accreditation Council for Continuing Medical Education (ACCME), the Dannemiller Memorial Educational Foundation requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commerical interest. Accordingly: John G. Bartlett, MD Louis B. Rice, MD Dennis L. Stevens, MD, PhD Gregory J. Moran, MD, FACEP Robert C. Moellering, Jr., MD, MACP Disclosure and Disclaimer Information Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, containdications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. Disclaimer: The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of the Dannemiller Memorial Educational Foundation, Arpida, or Exemplar CE. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity. Other Disclosures: The Dannemiller Staff and Exemplar CE staff who were involved in the development of this activity have no financial relationships with any commercial interests that are relevant to this activity. Resolution of Conflict: To resolve identified conflicts of interest, the educational content was fully peer reviewed by a physician member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based and commercially balanced. Commercial Support This program is supported by an educational grant from Arpida, Ltd. Technical Support You must allow pop-up windows to view the web cast and take the posttest. In order to take the posttest and receive your "CME Receipt of ours Completed" you must be connected to the Internet. To view the program you will need Adobe Flash Player – please click on the flash icon below if you need to download the player:
Click here to view presentation. Jointly Sponsored by Dannemiller Memorial Educational Foundation and Exemplar CE.
|
